Reaction of Irbesartan with Nitrous Acid Produces Irbesartan Oxime Derivatives, rather than <i>N</i>-Nitrosoirbesartan-Reference-Cited by-同舟云学术

Reaction of Irbesartan with Nitrous Acid Produces Irbesartan Oxime Derivatives, rather than N-Nitrosoirbesartan

Published:2022-03-21 Issue:4 Volume:26 Page:1236-1246
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Lin Jinsheng¹,Zhou Qiang¹,Jia Ru¹,Liu Wentao¹,Hou Huacui¹,Ma Jian¹,Li Dan¹,Chen Nuo¹,Chen Wenbin¹,Ye Jian¹,Hu Wenping¹,Zhu Wenquan¹,Li Min¹²^ORCID

Affiliation:

1. Center of Excellence for Modern Analytical Technologies (CEMAT), Huahai Pharmaceutical Co., Ltd., Xunqiao, Linhai 317024, Zhejiang, P. R. China

2. Huahai US, Inc., 700 Atrium Drive, Somerset, New Jersey 08873, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.1c00494

Reference24 articles.

1. Quantitative Analysis of Irbesartan in Pharmaceuticals and Human Biological Fluids by Voltammetry

2. Development, evaluation and characterization of surface solid dispersion for solubility and dispersion enhancement of irbesartan

3. Carcinogenesis in rats by nitrosodimethylamine and other nitrosomethylalkylamines at low doses

4. FDA Announces Voluntary Recall of Several Medicines Containing Valsartan Following Detection of An Impurity, 2018. https://www.fda.gov/news-events/press-announcements/fda-announces-voluntary-recall-several-medicines-containing-valsartan-following-detection-impurity (accessed December 07, 2021).

5. aStatement Alerting Patients and Health Care Professionals of NDMA Found in Samples of Ranitidine, 2019, https://www.fda.gov/news-events/press-announcements/statement-alerting-patients-and-health-care-professionals-ndma-found-samples-ranitidine.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices;Chemical Research in Toxicology;2024-08-19

2. Current Threat of Nitrosamines in Pharmaceuticals and Scientific Strategies for Risk Mitigation;Journal of Pharmaceutical Sciences;2023-05

3. Investigation of nirmatrelvir epimerization occurred in analytical sample solution by using high resolution LC-MSn, NMR, and hydrogen/deuterium exchange study;Journal of Pharmaceutical and Biomedical Analysis;2023-04

4. Current status and prospects of development of analytical methods for determining nitrosamine and N-nitroso impurities in pharmaceuticals;Talanta;2023-03

5. An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine formation in various pharmaceuticals;Saudi Pharmaceutical Journal;2023-02